Do you have questions about the use of investigational drugs for treatment purposes?
As part of the FDA Basics resource, FDA is hosting a webinar where you can learn more about access to investigational drugs. The featured speakers, Theresa Toigo, Director, Office of Special Health Issues and Richard Klein, HIV/AIDS Program Director, Office of Special Health Issues, will discuss what to consider when deciding whether to seek access to an investigational drug and the ways to access investigational drugs. There will be time for questions following the presentation.
The 30 minute webinar will be held next Tuesday, February 23, at 3 p.m. ET.
Transparency Initiative Coordinator
A recently published article, FDA Transparency Initiative: Opening FDA's "Black Box", in the January/February 2010 issue of FDLI Update provides an overview of the agency's Transparency Initiative. Check out the article for a view of the agency's overall plan.
Transparency Task Force